## Abstract ## Objectives: The objective of this study was to investigate functional effects of immunoadsorption (IA) in patients with chronic nonfamilial dilated cardiomyopathy (DCM) regarding clinical and humoral markers of heart failure. ## Background: IA has been shown to induce early hemody
Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy
β Scribed by Andreas O. Doesch; Mathias Konstandin; Sultan Celik; Arnt Kristen; Lutz Frankenstein; Stefan Hardt; Stefan Goeser; Ziya Kaya; Hugo A. Katus; Thomas J. Dengler
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 220 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Dilated cardiomyopathy (DCM) is a leading cause of endβstage heart failure and cardiac transplantation. Anticardiac antibodies are common and removal of these through immunoadsorption (IA) is associated with improvement in global cardiac function. The effect of IA on regional function a
Background: Certain cardiac-specific autoantibodies found in patients with dilated cardiomyopathy (DCM) play a role in mediating myocardial damage and fatal ventricular arrhythmias resulting in sudden cardiac death. Immunoadsorption therapy (IA) is one of the therapeutic tools to remove such autoant
## Abstract Autoβantibodies to myocardial antigens have been implicated in the pathogenesis of chronic dilated cardiomyopathy (DCM). A protein A immunoadsorption affinity column system was used to remove IgG antibodies, particularly IgG3. Two techniques, the standard technique (Tβ1) used for remova
Although amrinone has favorable hemodynamic effects in patients with congestive heart failure, little is known about its effects on coronary blood flow (CBF). We compared the effects of intravenous low-dose dobutamine and amrinone on CBF in 10 patients with dilated cardiomyopathy using a Doppler gui
## Abstract Genotypeβspecific effects of parvovirus B19 (B19V) infections on left ventricular function in patients with dilated cardiomyopathy (DCM) have not been investigated so far. In this prospective clinical study, the prevalences of B19V genotypes in endomyocardial biopsies from patients pres